Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, March 7, 2014, 162 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $252.67 to $79,694,022.59.

Highlighted Stocks Traded by Insiders:

Jack Henry & Associates (JKHY) - FREE Research Report

Wimsett Thomas A who is Director at Jack Henry & Associates bought 2,000 shares at $57.84 on March 7, 2014. Following this transaction, the Director owned 14,981 shares meaning that the stake was reduced by 15.41% with the 2,000-share transaction.

Forbis Mark S who is Vice President & Cto at Jack Henry & Associates sold 3,500 shares at $57.90 on March 7, 2014. Following this transaction, the Vice President & Cto owned 4,753 shares meaning that the stake was reduced by 42.41% with the 3,500-share transaction.

Kelly Laura G. who is Director at Jack Henry & Associates bought 1,000 shares at $54.64 on March 7, 2014. Following this transaction, the Director owned 3,820 shares meaning that the stake was reduced by 35.46% with the 1,000-share transaction.

The shares most recently traded at $57.56, up $2.92, or 5.08% since the insider transaction. Historical insider transactions for Jack Henry & Associates go as follows:

  • 4-Week # shares sold: 4,200
  • 12-Week # shares sold: 4,200
  • 24-Week # shares sold: 4,200

The average volume for Jack Henry & Associates has been 352,000 shares per day over the past 30 days. Jack Henry & Associates has a market cap of $4.9 billion and is part of the technology sector and computer software & services industry. Shares are down 2.69% year-to-date as of the close of trading on Friday.

Jack Henry & Associates, Inc. provides technology solutions and payment processing services primarily for financial services organizations in the United States. The stock currently has a dividend yield of 1.53%. The company has a P/E ratio of 25.2. Currently there are no analysts that rate Jack Henry & Associates a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JKHY - FREE

TheStreet Quant Ratings rates Jack Henry & Associates as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Jack Henry & Associates Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Home Properties (HME) - FREE Research Report

Hague Donald R. who is Senior Vice President at Home Properties sold 306 shares at $60.57 on March 7, 2014. Following this transaction, the Senior Vice President owned 17,700 shares meaning that the stake was reduced by 1.7% with the 306-share transaction.

The shares most recently traded at $59.67, down $0.90, or 1.51% since the insider transaction. Historical insider transactions for Home Properties go as follows:

  • 12-Week # shares bought: 850
  • 24-Week # shares bought: 850
  • 24-Week # shares sold: 310

The average volume for Home Properties has been 399,500 shares per day over the past 30 days. Home Properties has a market cap of $3.4 billion and is part of the financial sector and real estate industry. Shares are up 12.01% year-to-date as of the close of trading on Friday.

Home Properties, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It is engaged in the ownership, management, acquisition, rehabilitation and development of residential apartment communities. The stock currently has a dividend yield of 4.86%. The company has a P/E ratio of 35.8. Currently there are 2 analysts that rate Home Properties a buy, 3 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HME - FREE

TheStreet Quant Ratings rates Home Properties as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and a generally disappointing performance in the stock itself. Get the full Home Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Select Medical Holdings Corporation (SEM) - FREE Research Report

Romberger Scott A who is Senior Vice President at Select Medical Holdings Corporation sold 18,000 shares at $11.95 on March 7, 2014. Following this transaction, the Senior Vice President owned 208,830 shares meaning that the stake was reduced by 7.94% with the 18,000-share transaction.

The shares most recently traded at $11.59, down $0.36, or 3.11% since the insider transaction. Historical insider transactions for Select Medical Holdings Corporation go as follows:

  • 4-Week # shares sold: 9.7 million
  • 12-Week # shares sold: 13.2 million
  • 24-Week # shares sold: 21.2 million

The average volume for Select Medical Holdings Corporation has been 1.1 million shares per day over the past 30 days. Select Medical Holdings Corporation has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 1.46% year-to-date as of the close of trading on Friday.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals and outpatient rehabilitation clinics in the United States. It operates in two segments, Specialty Hospitals and Outpatient Rehabilitation. The stock currently has a dividend yield of 3.32%. The company has a P/E ratio of 14.7. Currently there are 2 analysts that rate Select Medical Holdings Corporation a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SEM - FREE

TheStreet Quant Ratings rates Select Medical Holdings Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and attractive valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Select Medical Holdings Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null